Ep135: John Maraganore on Developing a New Class of Medicines
May 08, 2023•1 hr 4 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
For the best experience, listen in Metacast app for iOS or Android